10.23.17
BASF on Monday celebrated the opening of a new state-of-the-art production plant for biocatalyzed acrylamide at its site in Nanjing Chemical Industrial Park, Nanjing, China.
With this investment in its wholly-owned BioACM plant in Nanjing, BASF is strengthening its production set-up for reliable and high-quality supply of polyacrylamide to customers in Asia Pacific, especially in China. The plant has a capacity of more than 50,000 tons of biocatalyzed acrylamide per year.
Acrylamide is used in the production of water-soluble flocculation aids that make wastewater treatment and papermaking, as well as mineral processing and enhanced oil recovery, more efficient and less resource-intensive. This new plant further strengthens BASF’s position in the region and will help expand cost-competitive supply to meet the growing demand of these water-intensive industries.
BASF has been producing biocatalyzed acrylamide in Suffolk, USA, since 2014 and started operations at its European BioACM plant in Bradford, England, in 2016. With this successful start-up in China, BASF now has three state-of-the-art production facilities located in key markets worldwide.
“The construction of a new polyacrylamide production line is currently underway and is expected to go on stream in 2018," said Andreas Tuerk, SVP, Paper and Water Chemicals, BASF. . "With investments into upstream and downstream plants, we continue to strengthen our position as a leading partner for the paper and water treatment industries."
The enzyme-based biocatalytic production method results in less waste than conventional high-pressure, energy-intensive copper catalysis. The process takes place at room temperature and under normal atmospheric conditions, resulting in energy savings and greater environmental compatibility. It also generates fewer by-products.
“The BioACM plant at Nanjing is built according to BASF’s high global standards of safety and environmental protection,” said Bradley Morrison, SVP, Operations and Site Management Greater China.
With this investment in its wholly-owned BioACM plant in Nanjing, BASF is strengthening its production set-up for reliable and high-quality supply of polyacrylamide to customers in Asia Pacific, especially in China. The plant has a capacity of more than 50,000 tons of biocatalyzed acrylamide per year.
Acrylamide is used in the production of water-soluble flocculation aids that make wastewater treatment and papermaking, as well as mineral processing and enhanced oil recovery, more efficient and less resource-intensive. This new plant further strengthens BASF’s position in the region and will help expand cost-competitive supply to meet the growing demand of these water-intensive industries.
BASF has been producing biocatalyzed acrylamide in Suffolk, USA, since 2014 and started operations at its European BioACM plant in Bradford, England, in 2016. With this successful start-up in China, BASF now has three state-of-the-art production facilities located in key markets worldwide.
“The construction of a new polyacrylamide production line is currently underway and is expected to go on stream in 2018," said Andreas Tuerk, SVP, Paper and Water Chemicals, BASF. . "With investments into upstream and downstream plants, we continue to strengthen our position as a leading partner for the paper and water treatment industries."
The enzyme-based biocatalytic production method results in less waste than conventional high-pressure, energy-intensive copper catalysis. The process takes place at room temperature and under normal atmospheric conditions, resulting in energy savings and greater environmental compatibility. It also generates fewer by-products.
“The BioACM plant at Nanjing is built according to BASF’s high global standards of safety and environmental protection,” said Bradley Morrison, SVP, Operations and Site Management Greater China.
